Results 101 to 110 of about 232,817 (297)

Histories in bone: Navigating the ethical landscape of human skeletal collections in South Africa

Anatomical Sciences Education, EarlyView.
Abstract Provenance is at the center of addressing the complicated ethical stewardship of legacy human skeletal collections. Many South African (SA) health science institutions have skeletal collections. While the history of the collections and the demographics of the skeletons have been reported, the provenance of the individuals within the ...
Quenth Chinenere, Beverley Kramer, Brendon K. Billings   +2 more
wiley   +1 more source

Essential work, invisible workers: The role of digital curation in COVID‐19 Open Science

Journal of the Association for Information Science and Technology, Volume 76, Issue 4, Page 703-717, April 2025.
Abstract In this paper, we examine the role digital curation practices and practitioners played in facilitating open science (OS) initiatives amid the COVID‐19 pandemic. In Summer 2023, we conducted a content analysis of available information regarding 50 OS initiatives that emerged—or substantially shifted their focus—between 2020 and 2022 to address ...
Irene V. Pasquetto, Amina A. Abdu, Natascha Chtena   +2 more
wiley   +1 more source

Chasing viruses feverishly

Journal of Family Medicine and Primary Care, 2017
A number of viral diseases have emerged and re-emerged in India and globally, in the last few years. Effective prevention and control of these diseases require, in addition to a functioning disease surveillance system, interventions both before and after
Chandrakant Lahariya
doaj   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Prevalence and factors associated with diabetes, hypertension, and ischemic heart disease and/or stroke multimorbidity in Morocco: Results of a national STEPS survey in 2017

Population Medicine
Introduction This study aimed to estimate the prevalence and associated factors of non-communicable diseases (NCDs) multimorbidity among adults in Morocco.
Karl Peltzer, Edith Phalane, Refilwe Phaswana-Mafuya   +2 more
doaj   +1 more source

Causes of Epidemics [PDF]

The Boston Medical and Surgical Journal
n ...
openaire   +2 more sources

AN EPIDEMIC OF CHOREA [PDF]

The Journal of Nervous and Mental Disease, 1891
n ...
openaire   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Seven challenges for metapopulation models of epidemics, including households models [PDF]

, 2015
This paper considers metapopulation models in the general sense, i.e. where the population is partitioned into sub-populations (groups, patches,...), irrespective of the biological interpretation they have, e.g. spatially segregated large sub-populations,
Frank Ball, Britton, Tom,, Mollison, Denis, Pellis, Lorenzo, Isham, Valerie, House, Thomas A., Ball, F, Ball, Frank, Pellis, L, Britton, T, Mollison, D, Pellis, Lorenzo; id_orcid, Tomba, Gianpaolo Scalia, Tom Britton, Scalia-Tomba, Gianpaolo, Lorenzo Pellis, House, Thomas; id_orcid, House, T, Denis Mollison, Britton, Tom, Scalia Tomba, Gianpaolo, Thomas House, Scalia Tomba, G, Gianpaolo Scalia Tomba, House, Thomas, Isham, V, Valerie Isham   +26 more
core   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source